mutLBSgeneDB |
Gene summary for DTNA |
![]() |
Basic gene Info. | Gene symbol | DTNA |
Gene name | dystrobrevin, alpha | |
Synonyms | D18S892E|DRP3|DTN|DTN-A|LVNC1 | |
Cytomap | UCSC genome browser: 18q12 | |
Type of gene | protein-coding | |
RefGenes | NM_001128175.1, NM_001198938.1,NM_001198939.1,NM_001198940.1,NM_001198941.1, NM_001198942.1,NM_001198943.1,NM_001198944.1,NM_001198945.1, NM_001390.4,NM_001391.5,NM_001392.4,NM_032975.3, NM_032978.6,NM_032979.4,NM_032980.3,NM_032981.4, | |
Description | dystrobrevin alphadystrophin-related protein 3 | |
Modification date | 20141207 | |
dbXrefs | MIM : 601239 | |
HGNC : HGNC | ||
Ensembl : ENSG00000134769 | ||
HPRD : 03141 | ||
Vega : OTTHUMG00000132309 | ||
Protein | UniProt: Q9Y4J8 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_DTNA | |
BioGPS: 1837 | ||
Pathway | NCI Pathway Interaction Database: DTNA | |
KEGG: DTNA | ||
REACTOME: DTNA | ||
Pathway Commons: DTNA | ||
Context | iHOP: DTNA | |
ligand binding site mutation search in PubMed: DTNA | ||
UCL Cancer Institute: DTNA | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
![]() |
GO ID | GO Term | PubMed ID |
Top |
Ligand binding site mutations for DTNA |
![]() We represented ligand binding site mutations only. (You can see big image via clicking.) ![]() |
![]() |
![]() |
LBS | AAchange of nsSNV | Cancer type | # samples | C246 | C246S | COAD | 1 | C270 | W272C | LUAD | 1 | C246 | C246S | LUSC | 1 | C258 | R257L | OV | 1 | H284 | M286I | STAD | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for DTNA |
![]() Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
![]() ![]() |
![]() |
![]() Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | C246 | C246S | -1.3307404 | H284 | M286I | -1.1969534 | C270 | W272C | -0.81175987 | C258 | R257L | -0.442017 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
![]() |
Top |
Differential gene expression and gene-gene network for DTNA |
![]() |
![]() |
Top |
Top |
Phenotype information for DTNA |
![]() |
Disease ID | Disease name | # PubMed | Association type |
umls:C1858725 | Noncompaction of Left Ventricular Myocardium, Familial Isolated, Autosomal Dominant 1 | 1 | Biomarker, GeneticVariation |
![]() |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for DTNA |
![]() Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
![]() |
![]() |
Drug status | DrugBank ID | Name | Type | Drug structure |
![]() |
![]() |
![]() |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS |
Top |
Conservation information for LBS of DTNA |
![]() |
LBS | AA sequence | # species | Species |
![]() |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |